NuVasive Dirección
Dirección controles de criterios 3/4
El CEO de NuVasive es Chris Barry , nombrado en Nov 2018, tiene una permanencia de 4.83 años. compensación anual total es $8.08M, compuesta por 11.1% salario y 88.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.14% de las acciones de la empresa, por valor de $2.90M. La antigüedad media del equipo directivo y de la junta directiva es de 3.7 años y 5.6 años, respectivamente.
Información clave
Chris Barry
Chief Executive Officer (CEO)
US$8.1m
Compensación total
Porcentaje del salario del CEO | 11.1% |
Permanencia del CEO | 4.8yrs |
Participación del CEO | 0.1% |
Permanencia media de la dirección | 3.7yrs |
Promedio de permanencia en la Junta Directiva | 5.6yrs |
Actualizaciones recientes de la dirección
Recent updates
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Apr 18What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?
Jan 24NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price
Dec 31Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Dec 05These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well
Nov 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Sep 22Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Sep 01NuVasive Likely Undervalued, But It's Hard To Find Catalysts
Aug 17Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Aug 11NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M
Aug 03NuVasive: Industry Tailwinds More Than Fairly Priced
Jun 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jun 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
May 11NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Apr 20At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?
Mar 30NuVasive's Turnaround Story Needs A Boost From Better Results
Mar 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
Dec 28Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?
Dec 02NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Nov 11NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate
Oct 21Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital
Sep 29At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?
Aug 18NuVasive Still Getting No Love With COVID-19 And Competitive Worries
Aug 12Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Jul 27Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?
Jun 17Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital
May 30Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All
May 12Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Mar 30Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?
Mar 09Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares
Feb 16A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jan 26NuVasive stock gains on study results of its X360 surgery approach
Jan 06What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 05Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Jun 30 2023 | n/a | n/a | US$28m |
Mar 31 2023 | n/a | n/a | US$20m |
Dec 31 2022 | US$8m | US$897k | US$40m |
Sep 30 2022 | n/a | n/a | -US$20m |
Jun 30 2022 | n/a | n/a | -US$40m |
Mar 31 2022 | n/a | n/a | -US$37m |
Dec 31 2021 | US$8m | US$875k | -US$64m |
Sep 30 2021 | n/a | n/a | -US$26m |
Jun 30 2021 | n/a | n/a | US$2m |
Mar 31 2021 | n/a | n/a | -US$50m |
Dec 31 2020 | US$5m | US$735k | -US$37m |
Sep 30 2020 | n/a | n/a | -US$9m |
Jun 30 2020 | n/a | n/a | -US$4m |
Mar 31 2020 | n/a | n/a | US$61m |
Dec 31 2019 | US$5m | US$800k | US$65m |
Sep 30 2019 | n/a | n/a | US$48m |
Jun 30 2019 | n/a | n/a | US$52m |
Mar 31 2019 | n/a | n/a | US$49m |
Dec 31 2018 | US$5m | US$92k | US$12m |
Compensación vs. Mercado: La compensación total de Chris($USD8.08M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD5.34M).
Compensación vs. Ingresos: La compensación de Chris ha sido consistente con los resultados de la empresa en el último año.
CEO
Chris Barry (50 yo)
4.8yrs
Permanencia
US$8,077,095
Compensación
Mr. J. Christopher Barry, also known as Chris, serves as Chief Executive Officer and Director of NuVasive, Inc., since November 5, 2018. Mr. Barry served commercial and leadership roles at Covidien. He has...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO & Director | 4.8yrs | US$8.08m | 0.14% $ 2.9m | |
Principal Accounting Officer | 3.7yrs | US$2.97m | 0.020% $ 418.2k | |
Senior Vice President of Global Operations | 3.7yrs | US$1.48m | 0.017% $ 355.5k | |
Senior VP | 5.3yrs | US$1.54m | 0.042% $ 869.2k | |
Senior Vice President of People & Culture | less than a year | US$1.03m | 0.0059% $ 123.8k | |
Senior VP & Chief Technology Officer | 2yrs | sin datos | sin datos | |
Vice President of Investor Relations | no data | sin datos | sin datos | |
Senior Vice President of Strategy & Corporate Development | 3.8yrs | sin datos | sin datos | |
Vice President & Head of Global Commercial Finance | 5.3yrs | sin datos | sin datos | |
Senior Vice President of Information Technology | 1.7yrs | sin datos | sin datos | |
Vice President | 5.3yrs | sin datos | sin datos |
3.7yrs
Permanencia media
48yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de NUVA se considera experimentado (3.7 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO & Director | 4.8yrs | US$8.08m | 0.14% $ 2.9m | |
Independent Director | 5.6yrs | US$260.01k | 0% $ 0 | |
Independent Director | 7.6yrs | US$260.01k | 0% $ 0 | |
Independent Director | 8.3yrs | US$280.01k | 0.0038% $ 79.4k | |
Independent Director | 4.9yrs | US$260.01k | 0.0026% $ 54.0k | |
Independent Chair | 8.2yrs | US$405.01k | 0% $ 0 | |
Independent Director | 9.3yrs | US$270.01k | 0.0059% $ 123.0k | |
Independent Director | 2.6yrs | US$260.01k | 0.0071% $ 148.7k | |
Independent Director | 2.1yrs | US$260.01k | 0% $ 0 |
5.6yrs
Permanencia media
59yo
Promedio de edad
Junta con experiencia: La junta directiva de NUVA se considera experimentada (5.6 años de antigüedad promedio).